Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 0.48 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.48 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | HTR2B | P41595 | 1/20 | 0.48 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 7/20 | 0.46 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | DHFR | P00374 | 1/20 | 0.37 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7535672 | 1.00 | NR1I2 (0.48) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| SCHEMBL8882786 | 0.79 | ADORA3 (0.55) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| SCHEMBL8882790 | 0.79 | ADORA3 (0.55) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| SCHEMBL7536263 | 0.77 | HIF1A (0.55) | HIF1AOPRL1POLBDHFRDCPS | |
| SCHEMBL7536259 | 0.77 | HIF1A (0.55) | HIF1AOPRL1POLBDHFRDCPS | |
| SCHEMBL8446155 | 0.77 | HTR1A (0.35) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| SCHEMBL8446154 | 0.77 | HTR1A (0.35) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| SCHEMBL2453671 | 0.75 | ADRB2 (0.39) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| SCHEMBL2453666 | 0.75 | ADRB2 (0.39) | NR1I2NR3C1HTR1AADORA3CNR1 | |
| SCHEMBL8534610 | 0.74 | MAPK1 (0.34) | NR1I2NR3C1HTR1AADORA3CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1094487-C | Oxime derivative and fungicide containing the same as active ingredient | SHIONOGI & CO (JP) | 2002-11-20 | — | — | CN | disclosed |
| US-6362212-B1 | POTENT FUNGICIDAL ACTIVITY | SHIONOGI & COMPANY, LTD. (JP) | 2002-03-26 | — | — | US | disclosed |
| US-20020032227-A1 | Oxime derivative and bactericide containing the same as active ingredient | TAKASE AKIRA (JP) | 2002-03-14 | — | — | US | disclosed |
| US-6268312-B1 | FUNGICIDES | SHIONOGI & CO., LTD. (JP) | 2001-07-31 | — | — | US | disclosed |
| US-6048885-A | FUNGICIDES | SHIONOGI & CO., LTD. (JP) | 2000-04-11 | — | — | US | disclosed |
| CN-1144524-A | Oxime derivative and fungicide containing the same as active ingredient | SHIONOGI & CO (JP) | 1997-03-05 | — | — | CN | disclosed |
| EP-0754684-A1 | OXIME DERIVATIVE AND BACTERICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT | SHIONOGI & CO., LTD. (JP) | 1997-01-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020032227-A1 | Oxime derivative and bactericide containing the same as active ingredient | MSMO1, O60361, CBR1 | NR1I2 853/4885NR3C1 426/4885HTR1A 2625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.